Aceso Life Science Group Past Earnings Performance
Past criteria checks 0/6
Aceso Life Science Group has been growing earnings at an average annual rate of 6.2%, while the Consumer Finance industry saw earnings declining at 1.5% annually. Revenues have been growing at an average rate of 2.7% per year.
Key information
6.2%
Earnings growth rate
16.8%
EPS growth rate
| Consumer Finance Industry Growth | -2.1% |
| Revenue growth rate | 2.7% |
| Return on equity | -20.3% |
| Net Margin | -212.1% |
| Last Earnings Update | 30 Sep 2023 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Aceso Life Science Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 198 | -420 | 123 | 0 |
| 30 Jun 23 | 203 | -342 | 125 | 0 |
| 31 Mar 23 | 207 | -264 | 126 | 0 |
| 31 Dec 22 | 135 | -301 | 134 | 0 |
| 30 Sep 22 | 115 | -338 | 141 | 0 |
| 30 Jun 22 | 143 | -354 | 147 | 0 |
| 31 Mar 22 | 170 | -370 | 153 | 0 |
| 31 Dec 21 | 8 | -197 | 162 | 0 |
| 30 Sep 21 | -154 | -25 | 171 | 0 |
| 30 Jun 21 | -141 | -200 | 188 | 0 |
| 31 Mar 21 | -129 | -376 | 204 | 0 |
| 31 Dec 20 | -43 | -523 | 209 | 0 |
| 30 Sep 20 | 43 | -671 | 213 | 0 |
| 30 Jun 20 | 9 | -477 | 201 | 0 |
| 31 Mar 20 | -25 | -284 | 189 | 0 |
| 31 Dec 19 | 48 | -162 | 196 | 0 |
| 30 Sep 19 | 120 | -40 | 203 | 0 |
| 30 Jun 19 | 148 | -211 | 211 | 0 |
| 31 Mar 19 | 175 | -381 | 219 | 0 |
| 31 Dec 18 | 200 | -533 | 223 | 0 |
| 30 Sep 18 | 224 | -686 | 226 | 0 |
| 30 Jun 18 | 237 | -565 | 226 | 0 |
| 31 Mar 18 | 250 | -445 | 227 | 0 |
| 31 Dec 17 | 235 | -1,209 | 205 | 0 |
| 30 Sep 17 | 220 | -1,972 | 183 | 0 |
| 30 Jun 17 | 169 | -2,526 | 158 | 0 |
| 31 Mar 17 | 118 | -3,079 | 133 | 0 |
| 31 Dec 16 | 95 | -1,911 | 119 | 0 |
| 30 Sep 16 | 71 | -743 | 106 | 0 |
| 30 Jun 16 | 57 | -109 | 97 | 0 |
| 31 Mar 16 | 42 | 524 | 89 | 0 |
| 31 Dec 15 | 20 | 498 | 80 | 0 |
| 30 Sep 15 | -1 | 471 | 70 | 0 |
| 30 Jun 15 | -3 | 997 | 73 | 0 |
| 31 Mar 15 | -5 | 1,523 | 75 | 0 |
| 31 Dec 14 | 6 | 1,281 | 79 | 0 |
| 30 Sep 14 | 17 | 1,039 | 82 | 0 |
| 30 Jun 14 | 22 | 466 | 80 | 0 |
| 31 Mar 14 | 26 | -107 | 78 | 0 |
| 31 Dec 13 | -13 | -122 | 67 | 0 |
| 30 Sep 13 | -52 | -137 | 56 | 0 |
| 30 Jun 13 | -27 | -134 | 56 | 0 |
Quality Earnings: 474 is currently unprofitable.
Growing Profit Margin: 474 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 474 is unprofitable, but has reduced losses over the past 5 years at a rate of 6.2% per year.
Accelerating Growth: Unable to compare 474's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 474 is unprofitable, making it difficult to compare its past year earnings growth to the Consumer Finance industry (13.1%).
Return on Equity
High ROE: 474 has a negative Return on Equity (-20.33%), as it is currently unprofitable.